Advertisement

Topics

XMS Capital Partners, LLC Company Profile

19:06 EDT 19th August 2018 | BioPortfolio

XMS Capital Partners, established in 2006, is a global, independent financial services firm providing investment banking, asset management and merchant banking services to clients. It has offices in Chicago, London and Dublin.


News Articles [1352 Associated News Articles listed on BioPortfolio]

Aleph Capital and Crestview Partners Agree to €260M Equity Funding Commitment in DARAG to ...

LONDON and NEW YORK, July 30, 2018 /PRNewswire/ -- Aleph Capital Partners LLP ("Aleph Capital") and Crestview Partners ("Crestview") have today announced that funds under Read more...

Medigene-Aktie: Rückzug von Leerverkäufer GSA Capital Partners hat an Dynamik gewonnen!

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP hat Netto-Leerverkaufsposition in Medigene-Aktien stark verringert: Die Leerverkäufer des Hedgefonds GSA Capital Partners L....

Medigene: Leerverkäufer GSA Capital Partners hat sich deutlich zurückgezogen

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP verringert Netto-Leerverkaufsposition in Medigene-Aktien signifikant: Die Leerverkäufer des Hedgefonds GSA Capital Partners....

CStone closes $260mm Series B round; largest in Chinese biopharm history

Immuno-oncology firm CStone Pharmaceuticals Co. Ltd. raised $260mm through its Series B round, the largest funding of its kind in Chinese biopharma history. GIC Private Ltd. led and was joined by new ...

Oversubscribed Series B brings $110mm to Precision BioSciences

Precision BioSciences (gene editing) raised $110mm through an oversubscribed Series B round. ArrowMark Partners led and was joined by new investors Franklin Templeton Investments, Cowen Healthcare Inv...

Medigene-Aktie: Short-Attacke von GSA Capital Partners geht weiter

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP stockt Netto-Leerverkaufsposition in Medigene-Aktien nun deutlicher auf: Die Leerverkäufer des Hedgefonds GSA Capital Partn....

TCR2 closes $125mm Series B round

TCR2 Therapeutics Inc. (immuno-oncology) raised $125mm through its Series B round. Curative Ventures and 6 Dimensions Capital co-led and were joined by additional new investors Redmile Group, ArrowMar...

Brii Biosciences launches with $260mm

Brii Biosciences has launched with committed funding of $260mm from Arch Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital, and Blue Pool Capital.

PubMed Articles [350 Associated PubMed Articles listed on BioPortfolio]

Health and social care coordination for severe and persistent mental illness in Australia: a mixed methods evaluation of experiences with the Partners in Recovery Program.

Care coordination has been identified as a person-centred response to the difficulty in meeting the needs of people with severe and persistent mental illness and complex needs. This study evaluated th...

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

"Who'll do all these if I'm not around?": Bonding social capital and health and well-being of inpatients.

Although social capital influences health-related decisions and behavioural patterns in many developing countries, minimal attention has been paid to the nuances of its effect on healthcare. This pape...

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Clinical Trials [349 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Companies [1877 Associated Companies listed on BioPortfolio]

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Thompson Street Capital Partners

Thompson Street Capital Partners has $450 million in capital under management. The private equity firm makes investments in manufacturing, service and distribution businesses. The fund's philosophy is...

Amulet Capital Partners, LP

Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long...

Harbinger Capital Partners

Harbinger Capital Partners is a multi-billion dollar private investment fund based in New York which employs a fundamental, intensive research-based approach to investing. ...

Sun Capital Partners, Inc.

Sun Capital Partners, Inc. is a leading private investment firm focused on leveraged buyouts, equity, debt, and other investments in companies that can benefit from its in–ho...

More Information about "XMS Capital Partners, LLC" on BioPortfolio

We have published hundreds of XMS Capital Partners, LLC news stories on BioPortfolio along with dozens of XMS Capital Partners, LLC Clinical Trials and PubMed Articles about XMS Capital Partners, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of XMS Capital Partners, LLC Companies in our database. You can also find out about relevant XMS Capital Partners, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record